Genprex Inc (GNPX)
2.51
+0.09
(+3.72%)
USD |
NASDAQ |
May 17, 16:00
2.51
0.00 (0.00%)
After-Hours: 20:00
Genprex Cash from Operations (Quarterly): -4.964M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -4.964M |
September 30, 2023 | -4.735M |
June 30, 2023 | -8.107M |
March 31, 2023 | -6.932M |
December 31, 2022 | -4.547M |
September 30, 2022 | -4.523M |
June 30, 2022 | -4.480M |
March 31, 2022 | -4.072M |
December 31, 2021 | -3.218M |
September 30, 2021 | -2.635M |
June 30, 2021 | -2.967M |
March 31, 2021 | -5.465M |
December 31, 2020 | -3.892M |
September 30, 2020 | -2.015M |
June 30, 2020 | -3.510M |
March 31, 2020 | -4.518M |
Date | Value |
---|---|
December 31, 2019 | -1.721M |
September 30, 2019 | -1.990M |
June 30, 2019 | -1.566M |
March 31, 2019 | -1.642M |
December 31, 2018 | -2.062M |
September 30, 2018 | -1.471M |
June 30, 2018 | -3.110M |
March 31, 2018 | -0.2037M |
December 31, 2017 | -0.2116M |
September 30, 2017 | -0.6389M |
June 30, 2017 | -0.6718M |
March 31, 2017 | -0.6493M |
December 31, 2016 | -0.8486M |
September 30, 2016 | -0.15M |
June 30, 2016 | -0.0902M |
March 31, 2016 | -0.1594M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-8.107M
Minimum
Jun 2023
-1.566M
Maximum
Jun 2019
-3.992M
Average
-4.072M
Median
Mar 2022
Cash from Operations (Quarterly) Benchmarks
Lifecore Biomedical Inc | -17.29M |
Jaguar Health Inc | -7.047M |
Aquestive Therapeutics Inc | -10.38M |
TFF Pharmaceuticals Inc | -4.214M |
Calidi Biotherapeutics Inc | -- |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -0.0098M |
Free Cash Flow | -24.81M |
Free Cash Flow Per Share (Quarterly) | -3.344 |
Free Cash Flow Yield | -711.6% |